Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ)

• Company Description    QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. Number of Employees: 6,500

• Price / Volume Information    Yesterday's Closing Price: $11.52 Daily Weekly Monthly 20 Day Moving Average: 2,419,591 shares Shares Outstanding: 68.61 (millions) Market Capitalization: $790.42 (millions) Beta: 0.77 52 Week High: $35.58 52 Week Low: $9.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.30% -15.21% 12 Week -14.22% -12.27% Year To Date -59.66% -63.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9975 SUMMERS RIDGE ROAD - SAN DIEGO,CA 92121 USA ph: 858-552-1100 fax: 858-453-4338 ir@quidelortho.com http://www.quidelortho.com

• General Corporate Information    Officers Brian J. Blaser - President and Chief Executive Officer Kenneth F. Buechler - Chairman of the Board Joseph M. Busky - Chief Financial Officer John R. Chiminski - Director Evelyn S. Dilsaver - Director Peer Information QuidelOrtho Corporation (BJCT) QuidelOrtho Corporation (CADMQ) QuidelOrtho Corporation (APNO) QuidelOrtho Corporation (UPDC) QuidelOrtho Corporation (IMTIQ) QuidelOrtho Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 219798105 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/26 Next Expected EPS Date: 02/10/27 Share - Related Items Shares Outstanding: 68.61 Most Recent Split Date: (:1) Beta: 0.77 Market Capitalization: $790.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.66 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/10/27

• Fundamental Ratios P/E Current FY Estimate: 17.45 Trailing 12 Months: 13.40 PEG Ratio: - Price Ratios Price/Book: 0.44 Price/Cash Flow: 0.61 Price / Sales: 0.30 EPS Growth vs. Year Ago Period: -61.25% vs. Previous Quarter: 138.46% Sales Growth vs. Year Ago Period: -11.57% vs. Previous Quarter: -1.90% ROE 09/30/26 - 3.22 06/30/26 - 4.88 03/31/26 - 4.25 ROA 09/30/26 - 1.03 06/30/26 - 1.63 03/31/26 - 1.56 Current Ratio 09/30/26 - 1.36 06/30/26 - 1.39 03/31/26 - 1.43 Quick Ratio 09/30/26 - 0.75 06/30/26 - 0.76 03/31/26 - 0.80 Operating Margin 09/30/26 - 2.28 06/30/26 - 3.46 03/31/26 - 3.44 Net Margin 09/30/26 - -14.24 06/30/26 - -39.20 03/31/26 - -45.57 Pre-Tax Margin 09/30/26 - -12.96 06/30/26 - -38.52 03/31/26 - -44.35 Book Value 09/30/26 - 26.11 06/30/26 - 25.88 03/31/26 - 27.15 Inventory Turnover 09/30/26 - 2.36 06/30/26 - 2.45 03/31/26 - 2.46 Debt-to-Equity 09/30/26 - 1.40 06/30/26 - 1.43 03/31/26 - 1.33 Debt-to-Capital 09/30/26 - 58.38 06/30/26 - 58.82 03/31/26 - 57.06

Powered by Zacks Investment Research ©